Route: Intramuscular (IM) or subcutaneous (SubQ)
Vanessa Mack (Dean) and her team provide ongoing guidance and monitor patient progress to help determine whether adjustments to a B12 injection schedule may be needed
Colchicine, Neomycin, Aminosalicylic Acid, H2-blockers (e.g., Ranitidine), and Proton Pump Inhibitors (PPIs, e.g., Omeprazole): These oral medications can all interfere with the intestinal absorption of dietary B12, making the need for injectable B12 more pronounced
Acknowledgements The authors would like to thank every researcher that contributed to the understanding of the close relationship between the IGF-1 deficiency and the Metabolic Syndrome establishment
Oral glucose tolerance testing revealed that AOD-9604 has no negative impact on carbohydrate metabolism
IM injections can help support patients with low levels or those requiring additional supplementation support